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Studies on the antibacterial and antifungal activities of the stem bark of Kigelia africana, (LAM). Benth 
(Family: Bignoniaceae), a medicinal plant used in South, Central and West Africa for the treatment of 
various ailments and infection was carried out using agar diffusion technique. The results revealed that 
the crude ethanolic extract exhibited antibacterial and antifungal activities against Staphylococccus 
aureus and Candida albicans with zones of inhibition measuring 15.0±0.95 and 20.75±4.6mm 
respectively. The aqueous extract exhibited no antibacterial or antifungal activity. The minimum 
inhibitory concentration for the extract was 6.25 ± 1.07 mg/ml for S. aureus and 7.92 ± 1.52 mg/ml for C. 
albicans. The ethanolic extract was also compared with various standards; Ampicillin, Gentamicin, 
Ceftriaxone and Ciprofloxacin. The ethanolic extract (20mg/ml) produced similar zone of inhibition with 
25µg disc of amoxicillin. 
 





Nature has been a source of medicinal agents for 
thousands of years and an impressive number of modern 
drugs have been isolated from natural sources, many of 
these isolations were based on the uses of the agents in 
traditional medicine (Cragg and Newman, 2001). This 
plant-based traditional medicine system continues to play 
an essential role in health care, with about 80% of the 
world’s inhabitants relying mainly on traditional medicines 
for their primary health care (Farnsworth et al., 1985). 
Kigelia africana is a plant that is widely distributed in the 
South, Central and West Africa. Locally known by 
Europeans as the cucumber or sausage tree because of 
the huge fruits (average 0.6 m in length and 4 kg in 
weight), which hangs from long fibrous stalks. The family 





*Corresponding author. E-mail: josphineomo@yahoo.com. Tel: 
08034120318. 
more than 20 m tall. It is found mostly in riverine areas 
where distribution is restricted to the wetter areas 
(Cordell, 2000). Venereal diseases are commonly treated 
with the extracts usually in palm wine as oral medication. 
The fruits and barks, grind and boiled in water, are also 
taken orally or used as enema in treating stomach 
ailments (Burkill, 1985). 
Most commonly, traditional healers have used the 
sausage tree to treat a wide range of skin ailments from 
relatively mild complaints such as fungal infections, boils, 
psoriasis and eczema, through to the more serious 
disease like leprosy, syphilis and skin cancer (Burkill, 
1985). Previous studies of the fruits of K. africana 
showed some antibacterial activity (Grace et al., 2002). 
However there is no report on the antibacterial and 
antifungal properties of the stem bark of this plant, this is 
needful as the organism; S. aureus is the most implicated 
organism in atopic eczema (Burkill, 1985). This report, 
therefore, presents studies on the antimicrobial properties 
of the alcoholic and aqueous extracts of the bark using 
clinical isolates of bacterial and fungal. 








The stem barks were collected based on ethno-pharmacological 
information.  The barks were collected in Okomu forest reserve, 
Udo in Benin City, Edo State. The botanical identity of the plant and 
its bark was by Alhaji Alasa Abubakar, of the Department of 
Pharmaco-gonosy, University of Benin, while it was authenticated 
at Forestry Research Institute of Nigeria (F.R.I.N., Ibadan) where a 
specimen (No FHI 107654) was deposited for future reference. 
Immediately after collection, the barks were cut into small pieces 
and dried under sunlight. The dried barks were pulverized into a 




Drugs and chemicals 
 
Absolute alcohol (Sigma-Aldrich), Mueller Hinton agar medium 
(Oxiod Limited., Basingstoke, England) Nutrient broth (oxoid cm 
31), Sabouraud dextrose broth (oxoid CM 41; Sigma – Aldrich) 
Amoxicillin, Ciprofloxacin, Gentamicin, Ceftriaxone (silva Hills) and 
Fluconazole (Drug field). 
 
 
Extraction of the plant material 
 
The powdered material (500 g) was mixed with absolute alcohol 
(2.5 l) and left for 72 h.  The mixture was stirred at 6 h intervals 
using a sterile glass rod, while another 500 g was placed into 4 l of 
distilled water and heated using a hot plate for 30 min. At the end, 
both extracts were filtered. The filtrates were concentrated in a 
vacuum (40oC), giving a yield of 3.78% for the ethanolic extract and 
10.74% for aqueous extract. They were then stored in universal 





Clinical Isolates of E. Coli, S. aureus, P. aeruginosa and the yeast 
C. albicans were all supplied by the Pharmaceutical Microbiology 
Department of the University of Benin. 
 
 
Preparation of medium 
 
Mueller–Hinton Agar was supplied by the Department of 
Pharmaceutical Microbiology, Faculty of Pharmacy University of 
Benin. Inocula of test organisms obtained from source were prepar-
ed by growing each pure isolate in Nutrient broth for 18 hours at 
37oC. The overnight broth culture was matched with macfarland 
turbidity standard to give an approximate 108 cfu/ml. 0.2mls was 
then used to seed a molten Mueller Hinton agar medium which has 
been allowed to cool to 45oC to obtain approximately 106 cfu/ml.  
This was poured into sterile Petri dishes and used for analysis (Ibeh 
et al 2002). 
 
 
Antimicrobial susceptibility testing 
 
The agar diffusion method described by Ver-poorte (1988) was 
used. Inocula of test organisms obtained from source were prepar-
ed by growing each pure isolate in Nutrient broth for 18 h at 37oC. 
The overnight broth culture was matched with macfarland turbidity 
standard to give an approximate 108 cfu/ml. 0.2 ml was then used 
to seed a molten Mueller Hinton agar medium which has been 
allowed to cool to 45oC to obtain approximately 106 cfc/ml. This was 
poured into sterile petri dishes and used for analysis.  





tration of each of the extracts with bacterial suspensions of 106 
organisms/ml. This was delivered into wells (8 mm in diameter) 
bored unto the surface of the already seeded Mueller Hinton agar 
plates. Equal volumes of distilled water and ethanol were assayed 
along to act as negative controls. Commercial discs containing 
amoxicillin 25 µg, ciprofloxacin 5 µg, gentamicin 10 µg, ceftriaxone 
30 µg and 20 mg/ml fluconazole served as positive controls for the 
antibacterial and anti-fungal activities. S. aureus (NCTC 10788) 
maintained in the pharmaceutical microbiology laboratory was set 
up along with the test organisms as a check on the effect of the 
media and inherent sensitivity of isolates on zones of inhibition 
produced by the anti-bacterial substances.  C. albicans was first 
grown on sabouraud dextrose broth and assayed using sabouraud 
dextrose agar. The plates were incubated at 37oC for 24 h while the 
plates containing the fungi were incubated at 25oC for 48 h. After 
incubation, zone of inhibition around the wells and the disc were 
measured and recorded. 
 
 
Minimum inhibitory concentration (MIC) 
 
The extracts were incorporated into Mueller Hinton agar at concen-
trations ranging from 2.5 mg/ml to 20 mg/ml. A control containing 
the growth medium and each of the test isolates was also set up. A 
loopful of the organisms previously diluted to 106 cfu/ml was used to 
inoculate the plates. These were incubated at appropriate tem-
peratures of 37oC for 24 h and 25oC for 48 h for the bacteria and 
fungi, respectively.  The MIC of the extract was regarded as the 
lowest concentration that did not permit growth of test organism.  
 
 
Acute toxicity test 
 
24 mice (20 – 25 g) of either sex were obtained from the Animal 
House of the Department of Pharmacology and Toxicology, Univer-
sity of Benin, Benin city. The animals were randomly divided into six 
(6) groups of four (4) mice each. The animals were fed with mice 
pellets and had free access to drinking water but starved for 12 h 
prior to testing. The first five groups were orally administered with 1, 
2, 4, 6 and 8 g/kg of ethanolic extract, respectively. The sixth group 
was given distilled water (10 ml/kg). General symptoms of toxicity 




RESULTS AND DISCUSSION 
 
The ethanolic extract of K. africana possess antibacterial 
and antifungal activity against S. aureus and C. albicans 
but not against the strains of Escherichia coli and P. 
aeruginosa tested (Table 1). The  water  extract  showed  
 
 
Table 1.  Mean zone diameter of clinical isolates to the ethanolic 
extract. 
 
Zone of inhibition (mm) Organisms 
Neat 20 mg 
Staphylococcus aureus 34.5 ±2.5 15.0 ±0.95 
Escherichia  coli - - 
Pseudomonas aeruginosa - - 
Candida albicans 24.8 ±1.53 0.75 ±4.6 
 
Mean taken was for 10 isolates. Values are mean zone of 
inhibitions in mm ± SEM. 
Zone measuring ≥ 10 mm was accepted as indicating sensitivity 
of an organism to an antimicrobial agent. 




Table 2. Comparison of the antimicrobial activity of commercial antibiotics against the ethanolic extract of Kigelia africana.  
 
Mean   zone of inhibition (mm) Organisms 
Extract (20 mg) GN (10 µg) CZ (30 µg) CIP (5 µg) AM (25 µg) F (20 mg) 
Staphylococcus aureus 15.0 ± 0.95 19.3 ±1.44 25.3 ±3.01 33.0 ±1.29 15.0 ±1.00 - 
Escherichia coli - 11.0 ±3.00 19.4 ±2.34 23.6 ±2.03 16.5 ±4.50 - 
Pseudomonas aeruginosa - 15.0 ±1.00 16.5 ±2.00 29.6 ±3.28 - - 
Candida albicans 20.75 ±4.60 - - - - 36.0 ±2.28 
 
Values are mean zone of inhibitions in mm ± SEM. 
Mean taken was for 10 clinical isolates. 




Table 3. Minimum inhibitory concentration (MIC) of the ethanolic 
extract of Kigelia africana. 
 
Organisms MIC (mg/ml) 
Staphylococcus  aureus 6.25 ± 1.07 
Escherichia  coli - 
Pseudomonas  aeruginosa - 
Candida albicans 7.92 ± 1.52 
 
Mean taken was for 10 isolates for Staphylococcus aureus and 6 
isolates for Candida albicans. 















Control  0 - 
1000 3.000 0 - 
2000 3.301 0 - 
4000 3.602 50 5.000 
6000 3.778 75 5.700 
8000 3.903 100 - 
 




no activity against all the organisms. The activity of 20 
mg/ml of the ethanolic extract of K. africana against S. 
aureus was found to be similar to that of 25 µg disc of 
amoxicillin (Table 2). The MIC was 6.25 ± 1.07 mg/ml for 
the ethanolic extract against S. aureus and 7.92 ± 1.520 
mg/ml against C. albican (Table 3). Distilled water and 
ethanol, which served as negative controls, produced no 
zones of inhibition. Table 4 shows the result of the acute 
toxicity test done on mice. The LD50 was estimated from 
a log-dose response curve (Figure 1) as 4 g/kg.   
The extract was well tolerated by the animals as no 
signs of acute toxic effects like restlessness, dizziness or 
seizures were observed after the administration at 1 – 2 
g/kg. However at 4 g/kg, the animals showed signs of 
toxicity like writhes and jerks, with 50%  death. At  6  g/kg  
 
 





there was 75% death. While at 8 g/kg, there was 100% 
death. 
The fact that the ethanolic extract of K. africana pro-
duced zones of inhibition against a Gram positive 
organism such as S. aureus and a fungus C. albicans 
indicate the presence of antimicrobial activity which con-
firms its use as anti-infection agent. However, it showed 
no activity against E. coli and P. aeruginosa thus 
indicating its narrow spectrum of activity. The aqueous 
extract showed no activity, indicating that ethanol is a 
better extracting solvent. S. aureus and C. albicans have 
been implicated in the pathology of atopic eczema and 
psoriasis (Watt and Breyer-Bradwijk, 1962). From the 
investigation carried out it shows that low doses of 6.25 
±1.07mg/ml and 7.92 ±1.52mg/ml of the ethanolic extract 
would inhibit the effect of these organisms causing these 
infections. This thus gives credence to its ethnopharma-
cological use as a remedy for these skin infections and 
other infections in which these organisms are implicated. 
The ethanolic extract was compared with respect to its 
antimicrobial activity  with  some  commercially  obtained  




antibiotics. This is shown in Table 3. Zones of inhibition 
against Staphylococcus aureus produced by the extract 
at 20mg were similar to that of 25µg disc of amoxicillin. 
However its zones of inhibition against Staphylococcus 
aureus were 78%, 60% and 45% of that produced by 
gentamicin, ceftriaxone and ciprofloxacin respectively 
(result not shown). For its antifungal activity the zones of 
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